Zerion Pharma A/S
CVR 40169229 · Public limited company (A/S) · Active · High risk
Zerion Pharma A/S is a Public limited company (A/S), founded on , based in København Ø. The company is registered in the industry fremstilling af farmaceutiske præparater. Our model estimates a bankruptcy risk of 3.4% over the next 12 months, which is 2.4 times the average for Danish companies. 7 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK -3.5m and a net result of DKK -10.8m. CEO: Ole Sylvester-Hvid Wiborg.
Bankruptcy risk for Zerion Pharma A/S
2.4 × the average (1.41%) · higher risk than 88% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 40169229
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (7 years)
- Address
- c/o SYMBION, Fruebjergvej 3
2100 København Ø - Municipality
- København
- Industry
- Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater - Share capital
- DKK 1.2m
- Auditor
- Cedra Godkendt Revisionsaktieselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 1 of 7 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | -31.8% |
| Current ratio | 293% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 1 |
| Other companies at the address | 611 |
| Going-concern uncertainty | Yes |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Revenue | DKK 3.4m | DKK 3.5m |
| Gross profit | DKK -4.8m | DKK -5.8m |
| Net profit | DKK -10.8m | DKK -220k |
| Equity | DKK -3.5m | DKK -2.3m |
| Total assets | DKK 11.1m | DKK 9.7m |
| Cash | DKK 3.6m | – |
| Short-term debt | DKK 3.2m | – |
| Avg. employees | 10 | – |
Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · Deloitte Statsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 176 | ||
| 1 Jan 2024 – 31 Dec 2024 | 177 | ||
| 1 Jan 2023 – 31 Dec 2023 | 197 | Late | |
| 1 Jan 2022 – 31 Dec 2022 | 180 | ||
| 1 Jan 2021 – 31 Dec 2021 | 158 | ||
| 1 Jan 2020 – 31 Dec 2020 | 131 | ||
| 14 Jan 2019 – 31 Dec 2019 | 126 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Ole Sylvester-Hvid Wiborg | Current | |
| Board | Jorrit Jeroen Water | Current | |
| Board | Dorte Juhl Arnbjerg | Current | |
| Board | Carl-Åke Carlsson | Current | |
| Board | Allan Stich | Current | |
| Board | Geelanie Rodriguez Briones | Current | |
| Board | Ole Sylvester-Hvid Wiborg | ||
| Board | Adam Jun Bohr | ||
| Board | Peter Mohan Christiansen | ||
| Board | Christian Bone Falk-Rønne | ||
| Board | Korbinian Arthur Maria Löbmann | ||
| Board | Lars Lykke Thomsen | ||
| Board | Torsten Rüdiger Goesch | ||
| Board | Torsten Rüdiger Goesch | ||
| Board | Lars Lykke Thomsen | ||
| Board | Geelanie Rodriguez Briones | ||
| Owner (5%) | WIBORG INTERNATIONAL HOLDING ApS | Current | |
| Owner (5%) | Waterman ApS | Current | |
| Owner (5%) | Running Man ApS | Current | |
| Owner (5%) | Bohring ApS | Current | |
| Owner (5%) | Mohan.dk ApS | Current | |
| Owner (5%) | Geelanie Rodriguez Briones | Current | |
| Owner (100%) | WIBORG INTERNATIONAL HOLDING ApS | ||
| Owner (5%) | CBFR ApS | ||
| Auditor | Cedra Godkendt Revisionsaktieselskab | Current | |
| Auditor | BAAGØE SCHOU STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Auditor | DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB | ||
| Founder | WIBORG INTERNATIONAL HOLDING ApS | Current |
The CEOs' other companies
Ole Sylvester-Hvid Wiborg – 7 other companies, of which 2 bankrupt
- CYTOVAC A/S Bankrupt 18 Mar 2025
- PLEXUS DANMARK ApS Bankrupt 25 Jan 2005
- CENGENT THERAPEUTICS EUROPE A/S Opløst
- Cura Nordic ApS Opløst
- Dispersome IP ApS Active
- WIBORG ApS Active
- ZIMPL ApS Active
Address history (1 moves)
| c/o SYMBION, Fruebjergvej 3, 2100 København Ø | |
| Blokken 11, st., 3460 Birkerød |
Former names
| Zerion Pharma A/S | – now |
| Zerion Pharma ApS | – |
| Zerion ApS | – |
Other companies at the same address
- A DIMENSION GROUP A/S Bankrupt
- A-SYNTESE BIOTECH ApS Bankrupt
- ABSTRACTION ApS Bankrupt
- ADURA ApS Bankrupt
- AFVIKLINGSSELSKABET AF 8.2.1999 A/S Bankrupt
- ALLEGENETICS DIAGNOSTICS LABORATORY ApS Bankrupt
- ANSARI GROUP S.M.B.A. Bankrupt
- AQUALIFE A/S Bankrupt
- AREA NETWORKS ApS Bankrupt
- ASD Group Denmark ApS Bankrupt
- Afsluttet Projektselskab BLN ApS Bankrupt
- Andersen & Andersen IVS Bankrupt
- Andersentraveller ApS Bankrupt
- ApS VICTORIA STREET KOMPLEMENTAR Bankrupt
- Autocycle International ApS Bankrupt
- BB Ejendomme 2015 IVS Bankrupt
- BB Jyllands investering IVS Bankrupt
- BB Jyllands projekt IVS Bankrupt
- BINCORE GROUP A/S Bankrupt
- BINCORE INDUSTRIES A/S Bankrupt
- BLUSENSE DIAGNOSTICS APS Bankrupt
- BRUUNS INVEST ApS Bankrupt
- BRUUNS REVISION ApS Bankrupt
- BUILD ApS Bankrupt
- Baunsgaard Technologies ApS Bankrupt
Similar companies in København
- H. LUNDBECK A/S Valby
- GUNNAR KJEMS ApS København K
- Tetrapharm Therapeutics ApS København S
- Tetrapharm Bioengineering ApS København S
- Luvalis Pharma ApS Vanløse
- NeuroVersis Therapeutics ApS København K
- QuantumCell ApS København K
- Vautia Therapeutics ApS København K
- Corxel Pharmaceuticals Denmark ApS København V
- Dispersome IP ApS København Ø
- Maddox Pharma Swiss ApS København S
- Gefjon Pharma ApS København N
Questions and answers about Zerion Pharma A/S
Has Zerion Pharma A/S gone bankrupt?
No, Zerion Pharma A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Zerion Pharma A/S?
Our model estimates a bankruptcy risk of 3.4% over the next 12 months (high risk), which is 2.4 times the average for Danish companies.
Who is the CEO of Zerion Pharma A/S?
Ole Sylvester-Hvid Wiborg is the CEO of Zerion Pharma A/S.
Who is the auditor of Zerion Pharma A/S?
Zerion Pharma A/S most recently used Cedra Godkendt Revisionsaktieselskab.
When was Zerion Pharma A/S founded?
Zerion Pharma A/S was founded on 14 January 2019.
What is the equity of Zerion Pharma A/S?
Equity was DKK -3.5m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.